Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4ID59
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 10 | 12 | PF00675 | 0.620 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.628 |
CLV_PCSK_KEX2_1 | 10 | 12 | PF00082 | 0.620 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.628 |
CLV_PCSK_SKI1_1 | 54 | 58 | PF00082 | 0.573 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.486 |
LIG_14-3-3_CanoR_1 | 10 | 20 | PF00244 | 0.400 |
LIG_14-3-3_CanoR_1 | 3 | 9 | PF00244 | 0.437 |
LIG_BRCT_BRCA1_1 | 44 | 48 | PF00533 | 0.376 |
LIG_BRCT_BRCA1_1 | 52 | 56 | PF00533 | 0.360 |
LIG_FHA_1 | 65 | 71 | PF00498 | 0.443 |
LIG_FHA_2 | 23 | 29 | PF00498 | 0.411 |
LIG_LIR_Gen_1 | 45 | 56 | PF02991 | 0.352 |
LIG_LIR_Nem_3 | 45 | 51 | PF02991 | 0.349 |
LIG_PCNA_yPIPBox_3 | 34 | 44 | PF02747 | 0.440 |
LIG_SH2_STAT5 | 69 | 72 | PF00017 | 0.387 |
LIG_SH3_3 | 107 | 113 | PF00018 | 0.632 |
LIG_SH3_3 | 86 | 92 | PF00018 | 0.409 |
LIG_TRAF2_1 | 129 | 132 | PF00917 | 0.638 |
LIG_TRAF2_1 | 25 | 28 | PF00917 | 0.480 |
MOD_CK1_1 | 42 | 48 | PF00069 | 0.375 |
MOD_CK2_1 | 22 | 28 | PF00069 | 0.394 |
MOD_GlcNHglycan | 13 | 16 | PF01048 | 0.682 |
MOD_GlcNHglycan | 79 | 82 | PF01048 | 0.644 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.390 |
MOD_GSK3_1 | 39 | 46 | PF00069 | 0.312 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.442 |
MOD_NEK2_1 | 26 | 31 | PF00069 | 0.408 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.380 |
MOD_PK_1 | 4 | 10 | PF00069 | 0.513 |
MOD_PKA_1 | 3 | 9 | PF00069 | 0.503 |
MOD_PKA_2 | 102 | 108 | PF00069 | 0.601 |
MOD_PKA_2 | 2 | 8 | PF00069 | 0.442 |
MOD_Plk_1 | 64 | 70 | PF00069 | 0.438 |
MOD_Plk_4 | 39 | 45 | PF00069 | 0.445 |
MOD_Plk_4 | 4 | 10 | PF00069 | 0.476 |
MOD_SUMO_for_1 | 115 | 118 | PF00179 | 0.695 |
TRG_ER_diArg_1 | 2 | 4 | PF00400 | 0.447 |
TRG_ER_diArg_1 | 9 | 11 | PF00400 | 0.425 |
TRG_NES_CRM1_1 | 39 | 52 | PF08389 | 0.387 |
TRG_Pf-PMV_PEXEL_1 | 107 | 111 | PF00026 | 0.480 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HZE1 | Leptomonas seymouri | 66% | 100% |
A0A0S4JIS2 | Bodo saltans | 32% | 100% |
A0A1X0P4N6 | Trypanosomatidae | 51% | 100% |
A0A3Q8IJB8 | Leishmania donovani | 100% | 100% |
A0A3S5IS04 | Trypanosoma rangeli | 46% | 96% |
A4HPK5 | Leishmania braziliensis | 86% | 100% |
D0A8K8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 55% | 100% |
E9ATB7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q4Q180 | Leishmania major | 96% | 100% |